{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:12:14Z","timestamp":1779207134643,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Startup Fund for scientific research, Fujian Medical University","award":["2022QH1076"],"award-info":[{"award-number":["2022QH1076"]}]},{"name":"Startup Fund for scientific research, Fujian Medical University","award":["2022QH1094"],"award-info":[{"award-number":["2022QH1094"]}]},{"name":"Sponsored by Fujian Provincial Health Technology Project","award":["2022QNA011"],"award-info":[{"award-number":["2022QNA011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-025-04173-9","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T14:11:38Z","timestamp":1767622298000},"page":"2099-2108","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum cancer testis antigen MAGEA3-IgG serves as a diagnostic biomarker in lung adenocarcinoma"],"prefix":"10.1007","volume":"28","author":[{"given":"Shuyu","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhan","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruifang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanli","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Falin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5958-6240","authenticated-orcid":false,"given":"Jianbin","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"issue":"3","key":"4173_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"4173_CR2","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.2147\/OTT.S248436","volume":"13","author":"H Zhang","year":"2020","unstructured":"Zhang H, Guo L, Chen J. Rationale for lung adenocarcinoma prevention and drug development based on molecular biology during carcinogenesis. Onco Targets Ther. 2020;13:3085\u201391.","journal-title":"Onco Targets Ther"},{"issue":"1","key":"4173_CR3","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1186\/s12935-021-02127-z","volume":"21","author":"A Al-Dherasi","year":"2021","unstructured":"Al-Dherasi A, Liao Y, Al-Mosaib S, Hua R, Wang Y, Yu Y, et al. Allele frequency deviation (AFD) as a new prognostic model to predict overall survival in lung adenocarcinoma (LUAD). Cancer Cell Int. 2021;21(1):451.","journal-title":"Cancer Cell Int"},{"issue":"5","key":"4173_CR4","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJMoa1102873","volume":"365","author":"DR Aberle","year":"2011","unstructured":"National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395\u2013409.","journal-title":"N Engl J Med"},{"key":"4173_CR5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/bs.acc.2015.07.003","volume":"72","author":"I Cho","year":"2015","unstructured":"Cho I. Lung cancer biomarkers. Adv Clin Chem. 2015;72:107\u201370.","journal-title":"Adv Clin Chem"},{"issue":"1","key":"4173_CR6","first-page":"77","volume":"102","author":"SNA Shah","year":"2025","unstructured":"Shah SNA, Aalam J, Parveen R. Deep learning approaches to enhance lung cancer diagnosis using next generation sequencing: state of the art. Arch Computat Methods Eng. 2025;102(1):77\u201382.","journal-title":"Arch Computat Methods Eng"},{"key":"4173_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107889","volume":"98","author":"X Meng","year":"2021","unstructured":"Meng X, Sun X, Liu Z, He Y. A novel era of cancer\/testis antigen in cancer immunotherapy. Int Immunopharmacol. 2021;98:107889.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"4173_CR8","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00428-024-03846-0","volume":"485","author":"S Forchhammer","year":"2024","unstructured":"Forchhammer S, Pop OT, Hahn M, Aebischer V, Seitz CM, Schroeder C, et al. Expression of the tumor antigens NY-ESO-1, tyrosinase, MAGE-A3, and TPTE in pediatric and adult melanoma: a retrospective case control study. Virchows Arch. 2024;485(2):335\u201346.","journal-title":"Virchows Arch"},{"issue":"11","key":"4173_CR9","first-page":"7002","volume":"12","author":"XF Li","year":"2020","unstructured":"Li XF, Ren P, Shen WZ, Jin X, Zhang J. The expression, modulation and use of cancer-testis antigens as potential biomarkers for cancer immunotherapy. Am J Transl Res. 2020;12(11):7002\u201319.","journal-title":"Am J Transl Res"},{"issue":"1","key":"4173_CR10","doi-asserted-by":"publisher","first-page":"7573","DOI":"10.1038\/s41598-024-58003-z","volume":"14","author":"Y Gan","year":"2024","unstructured":"Gan Y, Kang Y, Zhong R, You J, Chen J, Li L, et al. Cancer testis antigen MAGEA3 in serum and serum-derived exosomes serves as a promising biomarker in lung adenocarcinoma. Sci Rep. 2024;14(1):7573.","journal-title":"Sci Rep"},{"issue":"Pt A","key":"4173_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111041","volume":"125","author":"G Sun","year":"2023","unstructured":"Sun G, Chen H, Xia J, Li T, Ye H, Li J, et al. Diagnostic performance of anti-MAGEA family protein autoantibodies in esophageal squamous cell carcinoma. Int Immunopharmacol. 2023;125(Pt A):111041.","journal-title":"Int Immunopharmacol"},{"key":"4173_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.784925","volume":"11","author":"J Jin","year":"2021","unstructured":"Jin J, Tu J, Ren J, Cai Y, Chen W, Zhang L, et al. Comprehensive analysis to identify MAGEA3 expression correlated with immune infiltrates and lymph node metastasis in gastric cancer. Front Oncol. 2021;11:784925.","journal-title":"Front Oncol"},{"issue":"13","key":"4173_CR13","doi-asserted-by":"publisher","first-page":"4267","DOI":"10.1158\/1078-0432.CCR-11-0653","volume":"17","author":"S Bhan","year":"2011","unstructured":"Bhan S, Negi SS, Shao C, Glazer CA, Chuang A, Gaykalova DA, et al. BORIS binding to the promoters of cancer testis antigens, MAGEA2, MAGEA3, and MAGEA4, is associated with their transcriptional activation in lung cancer. Clin Cancer Res. 2011;17(13):4267\u201376.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"4173_CR14","first-page":"743","volume":"58","author":"S Lucas","year":"1998","unstructured":"Lucas S, De Smet C, Arden KC, Viars CS, Leth\u00e9 B, Lurquin C, et al. Identification of a new MAGE gene with tumor-specific expression by representational difference analysis. Cancer Res. 1998;58(4):743\u201352.","journal-title":"Cancer Res"},{"issue":"6","key":"4173_CR15","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1080\/09513590.2017.1291611","volume":"33","author":"M Sang","year":"2017","unstructured":"Sang M, Wu X, Fan X, Lian Y, Sang M. MAGE-A family serves as poor prognostic markers and potential therapeutic targets for epithelial ovarian cancer patients: a retrospective clinical study. Gynecol Endocrinol. 2017;33(6):480\u20134.","journal-title":"Gynecol Endocrinol"},{"issue":"8","key":"4173_CR16","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.prp.2017.05.007","volume":"213","author":"Y Lian","year":"2017","unstructured":"Lian Y, Sang M, Gu L, Liu F, Yin D, Liu S, et al. MAGE-A family is involved in gastric cancer progression and indicates poor prognosis of gastric cancer patients. Pathol Res Pract. 2017;213(8):943\u20138.","journal-title":"Pathol Res Pract"},{"issue":"4","key":"4173_CR17","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/1759-7714.12571","volume":"9","author":"L Gu","year":"2018","unstructured":"Gu L, Sang M, Yin D, Liu F, Wu Y, Liu S, et al. MAGE-A gene expression in peripheral blood serves as a poor prognostic marker for patients with lung cancer. Thorac Cancer. 2018;9(4):431\u20138.","journal-title":"Thorac Cancer"},{"issue":"6","key":"4173_CR18","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1136\/jclinpath-2016-203718","volume":"70","author":"M Sang","year":"2017","unstructured":"Sang M, Gu L, Yin D, Liu F, Lian Y, Zhang X, et al. MAGE-A family expression is correlated with poor survival of patients with lung adenocarcinoma: a retrospective clinical study based on tissue microarray. J Clin Pathol. 2017;70(6):533\u201340.","journal-title":"J Clin Pathol"},{"issue":"12","key":"4173_CR19","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1007\/s00262-012-1285-6","volume":"61","author":"RJ Inaoka","year":"2012","unstructured":"Inaoka RJ, Jungbluth AA, Gnjatic S, Ritter E, Hanson NC, Frosina D, et al. Cancer\/testis antigens expression and autologous serological response in a set of Brazilian non-Hodgkin\u2019s lymphoma patients. Cancer Immunol Immunother. 2012;61(12):2207\u201314.","journal-title":"Cancer Immunol Immunother"},{"key":"4173_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/bs.apcsb.2020.08.001","volume":"125","author":"B Das","year":"2021","unstructured":"Das B, Senapati S. Immunological and functional aspects of MAGEA3 cancer\/testis antigen. Adv Protein Chem Struct Biol. 2021;125:121\u201347.","journal-title":"Adv Protein Chem Struct Biol"},{"issue":"9","key":"4173_CR21","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1002\/ijc.21656","volume":"118","author":"J Kim","year":"2006","unstructured":"Kim J, Reber HA, Hines OJ, Kazanjian KK, Tran A, Ye X, et al. The clinical significance of MAGEA3 expression in pancreatic cancer. Int J Cancer. 2006;118(9):2269\u201375.","journal-title":"Int J Cancer"},{"issue":"1","key":"4173_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1159\/000493577","volume":"102","author":"EM Lausenmeyer","year":"2019","unstructured":"Lausenmeyer EM, Braun K, Breyer J, Gierth M, Denzinger S, Burger M, et al. Strong expression of cancertestis antigens CTAG1B and MAGEA3 is correlated with unfavourable histopathological features and MAGEA3 is associated with worse progression-free survival in urothelial bladder cancer. Urol Int. 2019;102(1):77\u201382.","journal-title":"Urol Int"},{"issue":"1","key":"4173_CR23","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13045-024-01637-3","volume":"17","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Zhang X, Lv Z, Huo H, Yuan L, Wan D, et al. Dynamically monitoring minimal residual disease using circulating tumour cells to predict the recurrence of early-stage lung adenocarcinoma. J Hematol Oncol. 2024;17(1):114.","journal-title":"J Hematol Oncol"},{"issue":"27","key":"4173_CR24","doi-asserted-by":"publisher","first-page":"4352","DOI":"10.3748\/wjg.14.4352","volume":"14","author":"EP Smorodin","year":"2008","unstructured":"Smorodin EP, Kurtenkov OA, Sergeyev BL, Kodar KE, Chuzmarov VI, Afanasyev VP. Postoperative change of anti-Thomsen-Friedenreich and Tn IgG level: the follow-up study of gastrointestinal cancer patients. World J Gastroenterol. 2008;14(27):4352\u20138.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"4173_CR25","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1158\/0008-5472.CAN-03-2646","volume":"64","author":"EA Danna","year":"2004","unstructured":"Danna EA, Sinha P, Gilbert M, Clements VK, Pulaski BA, Ostrand-Rosenberg S. Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease. Cancer Res. 2004;64(6):2205\u201311.","journal-title":"Cancer Res"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-04173-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-025-04173-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-04173-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:32:10Z","timestamp":1779204730000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-025-04173-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":25,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["4173"],"URL":"https:\/\/doi.org\/10.1007\/s12094-025-04173-9","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"7 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Fuzhou University Affiliated Provincial Hospital. The data used in this study were anonymized before use. The patients\/participants provided their written informed consent to participate in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}